Earnings Feed
Start Free
Home/Filings/3/0001209191-21-035377
3//SEC Filing

ATAI Life Sciences AG 3

Accession 0001209191-21-035377

CIK 0001098880other
View on SEC.govCompany Profile

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:57 PM ET

Size

13.2 KB

Accession

0001209191-21-035377

Insider Transaction Report

Form 3
Period: 2021-05-14
IntelGenx Technologies Corp.IGXT
ATAI Life Sciences B.V.
10% Owner
Holdings

  • Warrant (Right to Buy)

    → Common Stock, $0.00001 par value

  • Warrant (Right to Buy)

    Exp: 2024-05-14→ Common Stock, $0.00001 par value (130,000,000 underlying)

  • Common Stock, $0.00001 par value per share

    37,300,000

  • Warrant (Right to Buy)

    Exercise: $0.35Exp: 2024-05-14→ Common Stock, $0.00001 par value (22,380,000 underlying)
ATAI Life Sciences AG
10% Owner
Holdings

  • Warrant (Right to Buy)

    Exp: 2024-05-14→ Common Stock, $0.00001 par value (130,000,000 underlying)

  • Warrant (Right to Buy)

    Exercise: $0.35Exp: 2024-05-14→ Common Stock, $0.00001 par value (22,380,000 underlying)

  • Warrant (Right to Buy)

    → Common Stock, $0.00001 par value

  • Common Stock, $0.00001 par value per share

    37,300,000
Footnotes (4)
  • [F1]See Exhibit 99.1
  • [F2]See Exhibit 99.1
  • [F3]See Exhibit 99.1
  • [F4]See Exhibit 99.1

Documents

2 files

Issuer

IntelGenx Technologies Corp.

CIK 0001098880

→
Entity typeother
IncorporatedGermany

Related Parties

1
  • filerCIK 0001776242

Filing Metadata

Form type
3
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:57 PM ET
Size
13.2 KB
View on SEC.gov